BioCentury
ARTICLE | Company News

CombinatoRx, Accelerate Brain Cancer Cure, Duke University deal

October 4, 2004 7:00 AM UTC

CombinatoRx will use its combination high throughput screening (cHTS) platform to identify combination products that hit multiple targets relevant to treating glioblastoma multiforme (GBM). The univer...